Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Share-based Compensation (2021 - 2025)

Cannabist Co Holdings (CBSTF) has disclosed Share-based Compensation for 5 consecutive years, with $552000.0 as the latest value for Q3 2025.

  • Quarterly Share-based Compensation fell 76.75% to $552000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Sep 2025, up 119.87% year-over-year, with the annual reading at -$1.0 million for FY2024, 118.46% down from the prior year.
  • Share-based Compensation hit $552000.0 in Q3 2025 for Cannabist Co Holdings, down from $643000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $8.3 million in Q3 2023 to a low of -$12.8 million in Q4 2023.
  • Historically, Share-based Compensation has averaged $3.1 million across 5 years, with a median of $4.7 million in 2021.
  • Biggest YoY gain for Share-based Compensation was 112.3% in 2024; the steepest drop was 334.83% in 2024.
  • Year by year, Share-based Compensation stood at $7.0 million in 2021, then increased by 4.18% to $7.3 million in 2022, then plummeted by 276.34% to -$12.8 million in 2023, then skyrocketed by 112.3% to $1.6 million in 2024, then tumbled by 65.04% to $552000.0 in 2025.
  • Business Quant data shows Share-based Compensation for CBSTF at $552000.0 in Q3 2025, $643000.0 in Q2 2025, and $292000.0 in Q1 2025.